Baynes Roy D. bought AARD
August 14, 2026 · Form 4 insider transaction
Baynes Roy D. bought 44,964 shares of Aardvark Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 7 days after the transaction.
Direction
Acquired (buy-side)
Shares
44,964
Price
$0.00
Total value
N/A
InsiderBaynes Roy D.
RoleDirector
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateAugust 14, 2026
Filing dateAugust 21, 2026
Shares owned after44,964
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option shall vest in full on the earlier of (i) August 14, 2027, and (ii) immediately prior to the Registrant's next Annual Meeting of Stockholders following the date of grant, subject to the Reporting Person's continuous service through the applicable vesting date, inclusive.